Valsartan, Similar Drugs Not Linked To Increased Risks of COVID-19: Study
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.
New study questions whether hypertension drugs increase severity of COVID-19.
Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.
The FDA sent a warning letter to a South Korean drug manufacturer threatening to ban its products for the second time this year over manufacturing deficiencies.